UroGen Pharma (URGN) Update / Briefing June 13, 2025 08:30 AM ET Speaker0 Good day, and thank you for standing by. Welcome to the UroGen Pharma Zasturi Approval Investor Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Vincent Perrone, Head of Investor Relations. Please go ahead. Speaker1 ...